বৃহস্পতিবার, ৭ জুন, ২০১২

Dallas Plastic Surgeon, Dr. Andrew Trussler, Presents Chin Augmentation Webinar

Virgo

This is another good day for enjoying your working environment. Once again, everyone wants to help everyone else and there will be a terrific atmosphere. If you're looking for a new job, you hear something to your advantage now, or make some useful contacts. And if you're going to a job interview, you'll have good reason to be pleased with the way you handle it.

Credit - http://www.topix.com/med/plastic-surgery/2012/06/dallas-plastic-surgeon-dr-an...

Rev up your workouts with interval training

Interval training is a simple technique novice and experienced exercisers can use to get the most out of their workouts. Via - http://www.mayoclinic.com/health/interval-training/SM00110/rss=1

বুধবার, ৬ জুন, ২০১২

Genetics Alter Ability To Quit Smoking

The American Journal of Psychiatry reveals that whether or not a person is likely to stop smoking of their own accord or whether they need medication to assist them can now be determined by genetics. The finding could pave the way for health care providers to offer a more individualized therapy in the future to assist people in their quest to stop smoking. NIDA Director Nora D. Volkow, M... Source - http://www.medicalnewstoday.com/articles/246273.php

Aspirin - Cardiovascular Events Benefits Versus Major Bleeding Risk

Although daily low-dose aspirin may provide high-risk individuals with protection from cardiovascular events, a considerable number of people run a serious risk of major bleeding, researchers from Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy, reported in JAMA (Journal of the American Medical Association)... Source - http://www.medicalnewstoday.com/articles/246267.php

Well: Is Sunscreen Flammable?

Sunscreens sprayed from a can, just like hairspray, paints and deodorants, are flammable in the seconds after they have been applied, experts say.

Credit - http://feeds.nytimes.com/click.phdo?i=e68e99364bb61b0120b23150ea84ef1f

সোমবার, ৪ জুন, ২০১২

Dabrafenib And Trametinib For Metastatic Melanoma Meet Primary Endpoints In Phase III Studies

Phase III human trials of single agent therapy using dabrafenib and trametinib for patients with BRAF V600 mutation positive metastatic melanoma met their primary endpoints, GSK (GlaxoSmithKline) reported at the Annual Meeting of ASCo (American Society of Clinical Oncology), Chicago, Illinois, today. The trial results were also published today in NEJM (New England Journal of Medicine)... Credit - http://www.medicalnewstoday.com/articles/246163.php